logo

Shariah compliance overview

Halal

Tarsus Pharmaceuticals, Inc. (TARS) is currently classified as Halal by Akinda Shariah screening (AAOIFI-aligned methodology).

About Tarsus Pharmaceuticals, Inc.

Tarsus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm dedicated to advancing and commercializing innovative therapies, primarily focusing on ocular conditions.

Tarsus Pharmaceuticals, Inc. (TARS) operates in the Healthcare sector, in the Biotechnology industry.

Why it is halal: it passes all three AAOIFI screens. Non-compliant revenue is 3.37% (limit 5%), interest-bearing debt is 4.44% (limit 30%) and interest-bearing securities and assets are 22.31% (limit 30%).

If you hold TARS, give 3.37% of the dividends you receive to charity to purify the non-compliant share of its income.

Business Activity
3.37%Limit 5%Pass
Interest-bearing debt
4.44%Limit 30%Pass
Interest-bearing securities and assets
22.31%Limit 30%Pass
Dividend purification
3.37%Share of dividends to give to charityPurification calculator

Last updated: Nov 3, 2026 · Screening is informational and not a fatwa. Consult a qualified scholar for personal guidance.

Please login to access this content

Key stats

Please login to access this content

Please login to access this content

Company Profile

Please login to access this content

Frequently asked questions

Quick answers about Tarsus Pharmaceuticals, Inc. (TARS). Current Akinda screening label: Halal.